ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
EOM Pharmaceutical Holdings Inc (PK)

EOM Pharmaceutical Holdings Inc (PK) (IMUC)

0,20
0,00
(0,00%)
Fermé 11 Juin 10:00PM

EOM Pharmaceutical Holdings Inc (PK) (IMUC) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,20
( - )
Prix Achat
0,20
Prix Vente
0,20
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,036 Plage de 52 semaines 0,3399
Cap du marché
Clôture Veille
0,20
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 15 534
Actions en circulation
126 502 860
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-4
Bénéfice par action (BPA)
-0,05
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-5,13M

À propos de EOM Pharmaceutical Holdings Inc (PK)

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a pe... EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Montvale, United States
Fondé
2026
EOM Pharmaceutical Holdings Inc (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker IMUC. Le dernier cours de clôture d'EOM Pharmaceutical (PK) était de US$0,20. Au cours de la dernière année, les actions de EOM Pharmaceutical (PK) ont été négociées dans une fourchette de prix de US$ 0,036 à US$ 0,3399.

EOM Pharmaceutical (PK) compte actuellement 126 502 860 actions en circulation. La capitalisation boursière d'EOM Pharmaceutical (PK) est de US$25,30 million. EOM Pharmaceutical (PK) a un ratio cours/bénéfice (ratio PE) de -4.00.

IMUC Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0317.64705882350.170.270.126390800.21468706CS
40.04250.160.270.0821345520.16316668CS
120.040125.07817385870.15990.270.075133060.15417835CS
260.065448.5884101040.13460.270.07185990.13826053CS
520.092185.35681186280.10790.33990.03699630.11862743CS
156-0.0254-11.26885536820.22540.40.012362750.1519935CS
260-0.3602-64.2984648340.56020.940.012366660.30720616CS

IMUC - Frequently Asked Questions (FAQ)

What is the current EOM Pharmaceutical Holdings Inc (PK) share price?
The current share price of EOM Pharmaceutical Holdings Inc (PK) is US$ 0,20
How many EOM Pharmaceutical Holdings Inc (PK) shares are in issue?
EOM Pharmaceutical Holdings Inc (PK) has 126 502 860 shares in issue
What is the market cap of EOM Pharmaceutical Holdings Inc (PK)?
The market capitalisation of EOM Pharmaceutical Holdings Inc (PK) is USD 25,3M
What is the 1 year trading range for EOM Pharmaceutical Holdings Inc (PK) share price?
EOM Pharmaceutical Holdings Inc (PK) has traded in the range of US$ 0,036 to US$ 0,3399 during the past year
What is the PE ratio of EOM Pharmaceutical Holdings Inc (PK)?
The price to earnings ratio of EOM Pharmaceutical Holdings Inc (PK) is -4
What is the registered address of EOM Pharmaceutical Holdings Inc (PK)?
The registered address for EOM Pharmaceutical Holdings Inc (PK) is 136 Summit Avenue, Montvale, New Jersey, 07645
What is the EOM Pharmaceutical Holdings Inc (PK) website address?
The website address for EOM Pharmaceutical Holdings Inc (PK) is eompharma.com
Which industry sector does EOM Pharmaceutical Holdings Inc (PK) operate in?
EOM Pharmaceutical Holdings Inc (PK) operates in the Biotechnology & Life Sciences sector

IMUC Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock